November 27, 2024
1 min learn
Compensate for Healio’s information in diabetic retinopathy for Diabetes Consciousness Month.
Matters embrace AI screening software program, advantages of teleretinal screening and research outcomes.
November is Diabetes Consciousness Month. Picture: Adobe Inventory.
Q&A: AI software program presents cost-effective DR screening with out web entry
Divya Rao, MS, chief medical officer of Remidio, spoke with Healio about how Medios DR AI permits for extra reasonably priced and accessible diabetic retinopathy screening. Learn extra.
Teleretinal screening for diabetic retinopathy helpful
Teleretinal screening for diabetic retinopathy has a number of advantages, together with elevated capability and higher compliance. Learn extra.
VIDEO: OTX-TKI for NPDR exhibits promising security, tolerability at 48 weeks
Dilsher Dhoot, MD, of California Retina Consultants discusses interim security and efficacy outcomes for OTX-TKI for the remedy of nonproliferative diabetic retinopathy. Watch right here.
APX3330 oral remedy for diabetic retinopathy exhibits encouraging section 2 knowledge
APX3330, an investigational systemic remedy for diabetic retinopathy, confirmed encouraging outcomes within the section 2 ZETA-1 trial, paving the way in which to section 3. Learn extra.
VIDEO: Port supply system maintains enhancements in diabetic retinopathy at 2 years
Margaret Chang, MD, MS, of Retinal Consultants Medical Group presents 2-year outcomes for the port supply system with ranibizumab. Watch right here.
